HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Congenital cardiopathy

Procedural Rescheduling Criteria in the Pandemic Era

Patients with structural heart disease are at higher risk in the face of the new coronavirus infection...
solaci -
Learn More
Mitral valve

Promising Outcomes of Transcatheter Mitral Valve Replacement in Complex Patients

Courtesy of Dr. Carlos Fava. The risk of repeat surgical mitral valve repair involves 6% to15% mortality at...
solaci -
Learn More
Structural heart disease

Aortic Valvuloplasty as a Bridge to TAVR: Are We Wasting Our Time?

Doing a balloon aortic valvuloplasty can be a good way to “buy” time before a transcatheter aortic...
solaci -
Learn More
Other

Tricuspid valve: Is Percutaneous Intervention Feasible in Patients with Definite Pacemaker?

Courtesy of Dr. Carlos Fava. As we know, with higher life expectancy comes a significant increase in the...
solaci -
Learn More
Structural heart disease

Technological Improvements in Valves Translate into Clinical Results

Three generations of self-expanding valves, three different prognoses for our patients. Design improvements and better materials in...
solaci -
Learn More
Structural heart disease

Predilation in TAVR: Definitive Data for Easier Decision-Making?

Direct implantation (without predilation) resulted non-inferior vs. the conventional strategy with prior balloon aortic valvuloplasty using the...
solaci -
Learn More
STRUCTURAL HEART DISEASE

Virtual ACC 2020 | First Results of Evolut in Low-Risk Bicuspid Valves

The initial results of this study presented “virtually” at the American College of Cardiology (ACC) 2020 Scientific...
solaci -
Learn More
Antithrombotic Anticoagulants

Virtual ACC 2020 | POPULAR TAVR: Post TAVR Anticoagulation without Clopidogrel?

In patients undergoing transcatheter aortic valve replacement (TAVR) that also required anticoagulation for another indication (mostly atrial...
solaci -
Learn More